[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507256":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":36,"responsibleParty":102,"collaborators":32,"id":104,"slug":105,"hasResults":106,"nctId":107,"briefTitle":108,"officialTitle":108,"acronym":32,"eligibilityCriteria":109,"healthyVolunteers":110,"sex":111,"minAge":112,"maxAge":32,"enrollmentInfo":113,"targetDuration":32,"studyType":116,"phases":117,"briefSummary":119,"conditions":120,"keywords":32,"overallStatus":52,"whyStopped":32,"lastUpdateSubmitDate":122,"lastUpdatePostDateStruct":123,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":131},{"fullName":5,"class":6},"Myra Vision Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Investigational Device Arm","EXPERIMENTAL","Subjects will receive a Calibreye glaucoma device (permanent implant)",[13],"Device: Calibreye System",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Calibreye System","Implantation of a glaucoma device to reduce intraocular pressure",[9],[21],"Glaucoma device, Glaucoma implant, Aqueous Shunt",[23],{"name":24,"affiliation":25,"role":26},"Keith Barton, MD","Moorfields Eye Hospital NHS Foundation Trust","STUDY_CHAIR",[28,34],{"name":29,"role":30,"phone":31,"phoneExt":32,"email":33},"Shienal Patel","CONTACT","14085602500",null,"info@myravision.com",{"name":35,"role":30,"phone":31,"phoneExt":32,"email":33},"Michelle Tran",[37,50,69,85],{"facility":38,"status":39,"city":40,"state":32,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":32},"Dr. Agarwal's Eye Hospital Ltd.","ACTIVE_NOT_RECRUITING","Chennai","600018","India","IN",{"type":45,"coordinates":46},"Point",[47,48],80.27847,13.08784,{"lat":48,"lon":47},{"facility":51,"status":52,"city":53,"state":32,"zip":32,"country":54,"countryCode":55,"cosmosGeoPoint":56,"geoPoint":60,"contacts":61},"Centro Oftalmologico de Chihuahua","RECRUITING","Chihuahua City","Mexico","MX",{"type":45,"coordinates":57},[58,59],-106.08889,28.63528,{"lat":59,"lon":58},[62,66],{"name":63,"role":30,"phone":64,"phoneExt":32,"email":65},"Mayra Salinas","52 61 4364 7898","mayra_dj@hotmail.com",{"name":67,"role":68,"phone":32,"phoneExt":32,"email":32},"Ana Cristina Luna, MD","PRINCIPAL_INVESTIGATOR",{"facility":70,"status":52,"city":71,"state":32,"zip":72,"country":54,"countryCode":55,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Oftalmología Láser de Puebla S.C.","Puebla City","72540",{"type":45,"coordinates":74},[75,76],-98.20723,19.04778,{"lat":76,"lon":75},[79,83],{"name":80,"role":30,"phone":81,"phoneExt":32,"email":82},"Aimee Hernandez","(22) 2257-0970","aimeehdz20@gmail.com",{"name":84,"role":68,"phone":32,"phoneExt":32,"email":32},"Gabriel Salomón Lazcano Gómez, MD",{"facility":86,"status":52,"city":87,"state":32,"zip":32,"country":88,"countryCode":89,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"Panama Eye Center","Panama City","Panama","PA",{"type":45,"coordinates":91},[92,93],-79.51973,8.9936,{"lat":93,"lon":92},[96,100],{"name":97,"role":30,"phone":98,"phoneExt":32,"email":99},"Idabel Orillac","+507 269 7475","idabelo28@gmail.com",{"name":101,"role":68,"phone":32,"phoneExt":32,"email":32},"Lautaro Vera, MD",{"type":103,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR","100507256","feasibility-clinical-evaluation-of-the-calibreye-system-100507256",false,"NCT05885022","Feasibility Clinical Evaluation of the Calibreye System","Inclusion Criteria:\n\n* Open angle, pseudoexfoliative or pigmentary glaucoma\n* IOP at preoperative visit of ≥ 18mmHg and ≤ 45mmHg\n* Visual field mean deviation score of -3dB or worse\n* Area of healthy, free and mobile conjunctiva in the target quadrant\n* Shaffer angle grade ≥ 3 in the target quadrant\n\nExclusion Criteria:\n\n* Angle closure glaucoma\n* Congenital, neovascular or other secondary glaucomas\n* Previous intraocular surgery (with the exception of laser trabeculoplasty or uncomplicated phacoemulsification with IOL occurring \\> 3 months prior to the preoperative visit)\n* Previous glaucoma shunt\u002Fvalve in the target quadrant\n* Clinically significant inflammation or infection in the study eye within 30 days prior to the preoperative visit\n* History of corneal surgery, corneal opacities or corneal disease\n* Active diabetic retinopathy",true,"ALL","18 Years",{"count":114,"type":115},60,"ESTIMATED","INTERVENTIONAL",[118],"NA","To evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.",[121],"Glaucoma, Open-Angle","2025-12-08",{"date":124,"type":125},"2025-12-15","ACTUAL",{"date":127,"type":125},"2023-05-31",{"date":129,"type":115},"2028-12",{"name":5,"class":6},4]